Sökning: id:"swepub:oai:gup.ub.gu.se/328371" >
Incremental prognos...
Incremental prognostic value of biomarkers in PARADIGM-HF
-
McDowell, K. (författare)
-
Campbell, R. (författare)
-
Simpson, J. (författare)
-
visa fler...
-
Cunningham, J. W. (författare)
-
Desai, A. S. (författare)
-
Jhund, P. S. (författare)
-
Lefkowitz, M. P. (författare)
-
Rouleau, J. L. (författare)
-
- Swedberg, Karl, 1944 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
-
Zile, M. R. (författare)
-
Solomon, S. D. (författare)
-
Packer, M. (författare)
-
McMurray, J. J. V. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2023
- 2023
- Engelska.
-
Ingår i: European Journal of Heart Failure. - 1388-9842. ; 25:8, s. 1406-1414
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aims It is uncertain how much candidate biomarkers improve risk prediction when added to comprehensive models including routinely collected clinical and laboratory variables in heart failure. Methods and results Aldosterone, cystatin C, high-sensitivity troponin T (hs-TnT), galectin-3, growth differentiation factor-15 (GDF-15), kidney injury molecule-1, matrix metalloproteinase-2 and -9, soluble suppression of tumourigenicity-2, tissue inhibitor of metalloproteinase-1 (TIMP-1) and urinary albumin to creatinine ratio were measured in 1559 of PARADIGM-HF participants. We tested whether these biomarkers, individually or collectively, improved the performance of the PREDICT-HF prognostic model, which includes clinical, routine laboratory, and natriuretic peptide data, for the primary endpoint and cardiovascular and all-cause mortality. The mean age of participants was 67.3 +/- 9.9 years, 1254 (80.4%) were men and 1103 (71%) were in New York Heart Association class II. During a mean follow-up of 30.7 months, 300 patients experienced the primary outcome and 197 died. Added individually, only four biomarkers were independently associated with all outcomes: hs-TnT, GDF-15, cystatin C and TIMP-1. When all biomarkers were added simultaneously to the PREDICT-HF models, only hs-TnT remained an independent predictor of all three endpoints. GDF-15 also remained predictive of the primary endpoint; TIMP-1 was the only other predictor of both cardiovascular and all-cause mortality. Individually or in combination, these biomarkers did not lead to significant improvements in discrimination or reclassification. Conclusions None of the biomarkers studied individually or collectively led to a meaningful improvement in the prediction of outcomes over what is provided by clinical, routine laboratory, and natriuretic peptide variables.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Biomarkers
- Heart failure
- Prediction
- chronic heart-failure
- natriuretic peptide
- troponin-t
- risk
- predictors
- mortality
- sacubitril/valsartan
- morbidity
- enalapril
- survival
- Cardiovascular System & Cardiology
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
McDowell, K.
-
Campbell, R.
-
Simpson, J.
-
Cunningham, J. W ...
-
Desai, A. S.
-
Jhund, P. S.
-
visa fler...
-
Lefkowitz, M. P.
-
Rouleau, J. L.
-
Swedberg, Karl, ...
-
Zile, M. R.
-
Solomon, S. D.
-
Packer, M.
-
McMurray, J. J. ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
European Journal ...
- Av lärosätet
-
Göteborgs universitet